Educational content, not medical advice. Never stop or change RLS medication without your doctor; dopamine agonist withdrawal must be medically supervised.

RLS Atlas

Answers, cited

Restless legs syndrome: frequently asked questions

46 evidence-graded answers to the questions people ask most about restless legs syndrome, dopamine-agonist augmentation, iron therapy, and tapering — grouped by theme, each cited to a specific study or guideline.

Below are 46 evidence-graded answers to the most common questions about restless legs syndrome, dopamine-agonist augmentation, iron therapy, and tapering — each cited to a specific study or guideline.

Understanding RLS

What is restless legs syndrome (RLS)?

RLS is a chronic neurological condition causing an urge to move the legs, usually with an uncomfortable sensation, that is worse at rest, worse in the evening or night, and relieved by movement. Diagnosis requires five essential criteria, including ruling out other conditions that could explain the symptoms.

Evidence: D — IRLSSG diagnostic criteria, PMID 25023924

how restless legs syndrome works →

Is Willis-Ekbom disease the same as restless legs syndrome?

Yes. Willis-Ekbom disease is the renamed clinical term for restless legs syndrome, used interchangeably in the medical literature and by international guideline bodies (IRLSSG/EURLSSG). Both names refer to the same five-criteria diagnosis: urge to move the legs, worse at rest and in the evening, relieved by movement, and not explained by another condition.

Evidence: D, PMID 25023924

the mechanism behind restless legs syndrome →

Why are restless legs symptoms worse at night?

RLS follows the body clock, not just tiredness. Cortical and spinal inhibitory tone are both weakest at night, and dopamine's evening dip lands harder on a system whose receptors are already turned down. Endogenous melatonin's evening rise is the marker that best predicts the coming worsening, by about two hours.

Evidence: A for cortical hyperexcitability, PMID 39626363; C for the melatonin-timing finding, PMID 14991815

evening hyperarousal and the circadian dip →

What causes it

What causes restless legs syndrome?

The leading hypothesis is a local brain iron shortfall — not the iron measured in a standard blood count — that disrupts dopamine signalling in movement-control regions. Autopsy and spinal-fluid studies support this; the largest brain-MRI study to date did not confirm it, so it remains the field's strongest working hypothesis rather than a settled fact.

Evidence: C for CSF/autopsy findings, PMID 10762522 and 15136682; A for the contested MRI finding, PMID 35500370

brain iron deficiency, explained in full →

Can you have restless legs syndrome with normal blood iron levels?

Yes. Brain iron deficiency in RLS is believed to be local to the brain regions controlling movement, and can be present even when standard blood tests — including serum ferritin — look entirely normal. This is why guidelines set an RLS-specific ferritin threshold (75 ng/mL) that is much higher than the general anemia threshold.

Evidence: C, PMID 10762522; D for the guideline threshold, PMID 39324694

the iron-repletion step of the long-term plan →

Medication and augmentation

Why has my restless legs medication (pramipexole/Sifrol) stopped working?

The most likely explanation is augmentation — a complication where the drug itself gradually drives symptoms harder over time, not the underlying condition progressing. It is not a sign you need more of the drug. Roughly 7–10% of people on dopamine agonists develop it each year, compounding to about 42% by eight years in one specialist cohort.

Evidence: D, PMID 41563785; C, PMID 23036265

why dopamine agonists stop working →

What is augmentation in restless legs syndrome?

Augmentation is a drug-driven worsening seen with dopamine agonists: symptoms start earlier in the day (a shift of about four hours is the clearest sign), spread to the arms or trunk, appear sooner after sitting or lying down, and the drug wears off faster. Worsening after a dose increase is itself considered diagnostic.

Evidence: D — Max Planck/IRLSSG criteria, PMID 17544323

the full augmentation warning-signs checklist →

How common is dopamine agonist augmentation in RLS?

Roughly 7–10% of people on pramipexole, ropinirole, or rotigotine develop augmentation each year. In one specialist cohort it reached 42% by eight years, and a wider review found rates of 42–68% by around ten years. Because it compounds, longer time on the drug means higher cumulative risk, not stability.

Evidence: D, PMID 41563785 and 37840917; C, PMID 23036265

the augmentation timeline, month by month →

Should I increase my dose if my restless legs symptoms get worse?

No. Raising the dose to chase worsening symptoms is considered the single most damaging mistake in managing this condition — every guideline reviewed for this project says so. Worsening on a working dopamine agonist should be assumed to be augmentation until proven otherwise, which calls for reassessment, not a higher dose.

Evidence: D, PMID 27448465

how to recognize augmentation instead →

Why did guidelines stop recommending pramipexole for restless legs?

Because of augmentation. The American Academy of Sleep Medicine's 2024/2025 guideline gives a conditional recommendation against pramipexole, ropinirole, and rotigotine as standard therapy specifically on augmentation grounds — a reversal from its own 2012 guidance, which had rated these drugs at the highest recommendation level. Not every country's guideline agrees yet.

Evidence: D, PMID 39324694

the full guideline comparison →

Iron therapy

What ferritin level means I need iron treatment for restless legs?

Guidelines converge on a ferritin threshold of about 75 ng/mL, or a transferrin saturation under 20%: below that, oral or IV iron is indicated; between 75–100 ng/mL, IV iron only. This threshold is specific to RLS and higher than the general threshold used to diagnose iron-deficiency anemia.

Evidence: D, PMID 39324694, corroborated by the IRLSSG and German guidelines

Step 1 of the long-term plan: fix your iron →

Is IV iron or oral iron better for restless legs?

IV iron (ferric carboxymaltose, 1000 mg) produces a stronger effect: in the largest trial, recipients needed rescue medication far less often (33% versus 59%). Oral iron (about 65 mg elemental, alternate-day) produces a real but modest benefit, on average smaller than the placebo response seen across RLS trials. Neither is a guaranteed route off medication.

Evidence: B, PMID 38625730 and 27823710; A for the oral-iron pooled effect, PMID 30609006

the full evidence protocol's iron section →

How long does iron treatment take to improve restless legs symptoms?

Judge iron treatment at 12 weeks, not four — a major IV iron trial missed its effect at week four and reached significance at week twelve. Judging too early is a common reason people wrongly conclude iron "didn't work."

Evidence: B, PMID 28643901

realistic timelines for the long-term plan →

Medicines that make it worse

Which medications can make restless legs syndrome worse?

Two drugs account for most drug-triggered RLS: mirtazapine and quetiapine, usually within a day or two of starting or changing dose. Metoclopramide (an anti-nausea drug) and acid-suppressing drugs (proton-pump inhibitors, some H2-blockers) are also linked. Bupropion has the best safety record among antidepressants; SSRIs were not significantly linked in the largest safety database reviewed.

Evidence: B, PMID 42251748, 23456369, and 33119070; A, PMID 28822709

the full aggravating-drugs table →

Does melatonin help or worsen restless legs at night?

The evidence points the wrong way for most people: in a small, unblinded study, 3 mg of melatonin taken in the early evening significantly worsened objectively measured leg movements compared with baseline. Over-the-counter melatonin is specifically worth raising with your doctor if you are already taking it.

Evidence: C, PMID 20226733

medicines that make RLS worse →

Stopping a dopamine agonist safely

How do you safely stop taking pramipexole for restless legs?

Only under physician supervision, never abruptly. The safe sequence adds the replacement medication and gets it working at an effective dose before the dopamine agonist is reduced at all — even small reductions can trigger severe rebound. No trial has established a specific taper percentage or interval; your prescriber sets small, individualized steps.

Evidence: D, PMID 35609673; SOLUTION_PROTOCOL.md Phase 2

why stopping abruptly is dangerous →

What is dopamine agonist withdrawal syndrome (DAWS)?

DAWS is a severe, dose-dependent reaction some people have when a dopamine agonist is reduced or stopped: anxiety, panic, dysphoria, suicidal thinking, orthostatic hypotension, and drug craving. It resists being reversed just by going back on the drug and has no proven effective treatment. How common it is specifically in RLS, rather than Parkinson's, is not established.

Evidence: D, PMID 23686524 and 41870480

the DAWS warning in full →

What happens if I stop a dopamine agonist abruptly?

Rebound symptoms typically peak within days to about two weeks, and DAWS effects on mood can persist for months in some people. RLS itself roughly doubles the risk of suicidal thoughts or self-harm, and a taper is exactly when that risk concentrates — which is why abrupt stopping is specifically warned against, and why any change should be physician-supervised.

Evidence: D, PMID 23686524; B, PMID 31441941

the supervised-transition step of the plan →

Is there a standard taper schedule for coming off pramipexole?

No — this is an honest gap. No randomized trial has compared taper rates, and no guideline reviewed for this project gives a numeric taper schedule. A commonly repeated "10–25% every 2–4 weeks" rule could not be traced to any source in this knowledge base. Decrement size and interval are set individually by the prescriber.

Evidence: D — SOLUTION_PROTOCOL.md §3, "the honest position"

the full protocol's phase plan →

Alternatives to dopamine agonists

Is gabapentin better than pramipexole for restless legs?

For symptom relief, a network meta-analysis of 35 trials found gabapentin enacarbil, pregabalin, and rotigotine statistically indistinguishable. The key difference is augmentation risk: in a head-to-head trial, augmentation occurred in 2.1% on pregabalin versus 7.7% on pramipexole over 40–52 weeks. Alpha-2-delta drugs are, however, weaker specifically at suppressing periodic limb movements during sleep.

Evidence: A, PMID 28888061 and 23746768; B, PMID 24521108

gabapentin and pregabalin compared to agonists →

Are gabapentin and pregabalin safe for long-term restless legs treatment?

No reviewed trial links this drug class to augmentation, so a working alpha-2-delta ligand does not need tapering to prevent it. Long-term users should still be monitored for dose creep and, especially with pregabalin, misuse risk. In kidney impairment, gabapentin's elimination half-life can stretch dramatically, which has caused reversible neurotoxicity when dosing was not adjusted.

Evidence: C, PMID 28144823 and 33613345; E, PMID 36518357

what gabapentin and pregabalin do differently →

Non-drug therapy

Does the TOMAC/Nidra nerve stimulation device work for restless legs?

It is the only non-drug therapy recommended by the AASM's 2025 guideline: in a sham-controlled trial, 45% responded versus 16% on sham. Honestly, the pooled effect across trials sits below what an individual would typically notice, and the supporting research is largely manufacturer-funded.

Evidence: B, PMID 37458698; A, PMID 41581285

the evening non-drug toolkit →

Can exercise reduce restless legs symptoms?

Yes — structured aerobic-plus-resistance exercise, three times a week for at least twelve weeks, has trial support. In one dialysis-population study it roughly matched the effect of low-dose ropinirole while also adding lean muscle mass. This is a standing programme, not a last-minute bedtime workout.

Evidence: B, PMID 16951298 and 24024727

non-drug measures in the long-term plan →

The simulation and realistic expectations

Is the RLS Atlas simulation a tool that predicts my personal outcome?

No. It is an explicitly mechanistic teaching model — a hypothesis built from published evidence, not a new fact about any individual. It has no patient-specific calibration data, cannot forecast what will happen to you, and must never be used to start, stop, or change a dose. Every number it produces is labelled "not clinical prediction."

Category (iii) per project honesty rules — simulation/EXPLAINER.md, docs/SIMULATION_SPEC.md

what the simulation predicts, and what it doesn't →

Can restless legs syndrome improve or go away without treatment?

Sometimes. In a ten-year Finnish cohort, roughly half of the people who had frequent RLS at the start reported rare or no symptoms a decade later — with no treatment at all. Because the average placebo response in RLS trials is itself substantial (6.58 points on a 40-point scale), any uncontrolled improvement should be read cautiously.

Evidence: B, PMID 21725862; A, PMID 28490647

how claims on this site are graded and verified →

Diagnosis and finding care

How is restless legs syndrome diagnosed?

Restless legs syndrome is diagnosed clinically, by symptom criteria, not by a blood test or brain scan. The updated international (IRLSSG) criteria require five things: an urge to move the legs, usually with an uncomfortable sensation; worse at rest; relieved by movement; worse in the evening or night; and not better explained by another condition. All five must be present.

Evidence: D — IRLSSG updated diagnostic criteria, PMID 25023924

the full symptom and diagnosis picture →

What conditions can be mistaken for restless legs syndrome?

The fifth diagnostic criterion exists specifically to rule out look-alikes: leg cramps and positional discomfort are the two the guideline names directly. Peripheral neuropathy can also produce a similar sensory picture — restless legs syndrome is notably more common in polyneuropathy patients with small-fiber involvement — and antipsychotic-induced akathisia can resemble it too. A specialist assessment, not self-diagnosis, sorts these out.

Evidence: D, PMID 25023924; C, PMID 16685701 for the neuropathy overlap; D, PMID 37864837 for the akathisia-mechanism overlap

who can assess this properly →

Which doctor treats restless legs syndrome — a neurologist or a sleep specialist?

Both. Guideline literature names neurologists and sleep-medicine physicians as the specialists who manage restless legs syndrome, particularly once first-line measures haven't worked or augmentation is suspected. A primary-care physician can start the initial workup — especially ferritin and transferrin saturation testing — before a referral is needed.

Evidence: D, PMID 30075957 — French expert consensus naming neurologists and sleep specialists; D, PMID 39324694 — AASM 2025 guideline on primary-care iron testing

how to find one, and what to bring →

What is the RLS Foundation, and can it help me find a specialist?

The Restless Legs Syndrome Foundation (rls.org) is a US-based patient organisation that maintains a "Find a Doctor" directory and a network of certified RLS Quality Care Centers. Similar national patient organisations exist in several other countries — see the full list on this site's specialist-finder page.

Organisational information, not a graded clinical claim — verified directly against rls.org

the full list of patient organisations by country →

Medicines and triggers

Does mirtazapine cause or worsen restless legs syndrome?

Yes — mirtazapine has the strongest evidence of any antidepressant for triggering or worsening restless legs syndrome. In one prospective cohort, 28% of people starting mirtazapine developed or worsened it, versus 0% on reboxetine. Together with the antipsychotic quetiapine, mirtazapine accounts for the large majority of drug-induced restless legs cases in the largest available pharmacovigilance dataset.

Evidence: B, PMID 18468624; B, PMID 42251748

the full aggravating-drugs table →

What triggers restless legs symptoms specifically at night, besides the body clock?

Prolonged immobility is one confirmed trigger: leg-specific tissue oxygen drops during enforced stillness, tracks with symptom severity, and is partly reversed by pramipexole — one reason sitting still for long stretches (a car ride, a flight, a movie) tends to bring symptoms on. Alcohol and caffeine's roles are genuinely mixed in the evidence and should not be presented as settled either way.

Evidence: B, PMID 24789861 for immobility-linked leg hypoxia; evidence for alcohol and caffeine is inconsistent and not strong enough to grade either direction

the evening and night-time mechanism in full →

Pregnancy

How common is restless legs syndrome during pregnancy?

Very common — a meta-analysis of 27 studies (51,717 pregnant subjects) found a pooled prevalence of 21% overall, rising by trimester: 8% in the first, 16% in the second, and 22% in the third. Regional estimates ranged from 14% to 30%, but every region studied showed pregnancy substantially raising restless legs syndrome risk compared with non-pregnant women.

Evidence: A, PMID 29169861

restless legs syndrome in pregnancy, in full →

Does restless legs syndrome go away after pregnancy?

Often, yes — prevalence falls from roughly 22% in the third trimester to about 4% within weeks of delivery in the largest pooled data. But it isn't universal: one large prospective cohort found cumulative incidence kept rising to 34.7% by 12 months postpartum, and pregnancy-onset restless legs syndrome raises the odds of it recurring in future pregnancies or becoming a longer-term condition.

Evidence: A, PMID 29169861; B, PMID 40709818

what pregnancy remission does and doesn't tell us →

What can I safely do about restless legs syndrome while pregnant?

Guidelines recommend non-drug measures and iron-status testing and correction first, with any medication decision made only with your physician, given limited pregnancy-specific drug-safety data. Progressive muscle relaxation has randomized-trial support specifically in pregnancy for both restless legs severity and sleep quality, with no reported harms.

Evidence: D, PMID 25553600; D, PMID 32054396; B, PMID 37146530

the full pregnancy management picture →

Is it safe to take iron or gabapentin for restless legs syndrome while pregnant?

Only your physician can weigh this for you specifically, but the available safety signals are cautiously reassuring. Pooled first-trimester gabapentin-exposure registries (294 exposures) found a major-malformation rate comparable to the general-population background. For iron, IV iron more reliably corrected deficiency than oral iron in one pregnancy trial, though that trial measured anemia, not restless legs, as its outcome.

Evidence: D, PMID 25195202; B, PMID 36107229

how iron repletion works in the long-term plan →

Periodic limb movement disorder

What is periodic limb movement disorder (PLMD), and how is it different from restless legs syndrome?

Periodic limb movements in sleep (PLMS) are repetitive leg jerks most people with restless legs syndrome also have. Periodic limb movement disorder (PLMD) is a separate diagnosis for significant PLMS occurring without meeting the criteria for restless legs syndrome or another explanation — restless legs syndrome is diagnosed by symptoms, PLMD by an overnight sleep study.

Evidence: D, PMID 25023924; B, PMID 26703954

PLMS, PLMD, and RLS explained in full →

How is periodic limb movement disorder diagnosed, and what causes leg jerking at night?

By overnight polysomnography (a sleep study), not by symptoms alone. A periodic limb movement index above 15 per hour is the commonly used clinically-significant threshold for the repetitive leg jerks behind it, though the exact scoring rules are contested — two accepted scoring systems disagree, and both appear to over-count movements in people who also have sleep apnea.

Evidence: B, PMID 26703954; B, PMID 25325500

how PLMS is measured, and its limits →

Can periodic limb movements be treated, and does treating them help sleep?

Dopamine agonists reliably suppress periodic limb movements — but a controlled trial found a single dose did not reduce the underlying cortical arousal instability, while clonazepam did the reverse. That means reducing the movement count alone should not be assumed to fully fix sleep quality. Cognitive behavioral therapy matched clonazepam on sleep-log measures in one classic small trial.

Evidence: B, PMID 22718547; C, PMID 8843536

the evening non-drug toolkit →

What genuinely helps

What can I do tonight to stop restless legs symptoms, without medication?

Honestly, there is no reliably fast fix backed by controlled evidence — most of what works well (iron repletion, exercise programmes, progressive muscle relaxation) takes weeks, not one night. Right now, patients report mentally engaging distraction, self-administered warm or cool leg treatments, and moving or stretching the legs as helpful; none of this is proven in a controlled trial, but none is known to cause harm either.

Evidence: C, PMID 41244955 — qualitative patient-reported coping strategies, not a controlled trial

the evidence-graded evening toolkit →

Does exercise help restless legs syndrome, and when should I do it?

Yes — structured aerobic-plus-resistance exercise, three times weekly for at least twelve weeks, has randomized-trial support, in one dialysis-population study roughly matching the effect of low-dose ropinirole. The commonly repeated advice to avoid exercising close to the evening symptom peak is plausible but has not actually been tested — treat it as a reasonable guess, not proven advice.

Evidence: B, PMID 16951298 and 24024727; no evidence found either way for exercise-timing advice

non-drug measures in the long-term plan →

Can progressive muscle relaxation or stretching relieve restless legs symptoms?

Yes, with randomized-trial support in two different populations: a 117-patient trial in hemodialysis patients and a 52-patient trial in pregnant women both found progressive muscle relaxation significantly improved restless legs severity, sleep quality, and mood. Neither trial has yet been repeated in the general, non-pregnant, non-dialysis population most affected by long-term dopamine-agonist use.

Evidence: B, PMID 40954628; B, PMID 37146530

the evening non-drug toolkit →

What people call it

Why do my legs feel shaky, jumpy, or jittery when I sit still?

This is a hallmark of restless legs syndrome, not a tremor: one of the five diagnostic criteria specifically requires symptoms that appear or worsen with rest — sitting, lying down, or staying still — and ease with movement. People describe this in many ways: shaky, jumpy, jittery, twitchy, or fidgety legs; the sensation and the trigger are what identify it, not the specific word chosen.

Evidence: D — IRLSSG updated diagnostic criteria, PMID 25023924

the full symptom and diagnosis picture →